Dear Editor,

Carbapenem-resistant Enterobacteriaceae have acquired carbapenemase genes \[[@B1]\], which differ substantially across countries \[[@B2]\]. Transferable carbapenemase IMP-type metallo-β-lactamases, particularly IMP-1 and IMP-6, are commonly identified in the clinical setting in Japan \[[@B3][@B4]\] and exhibit different substrate specificity despite having a difference of only one amino acid (IMP-6: Ser214Gly). IMP-1 producers are more resistant to imipenem than to meropenem, whereas IMP-6 producers are more resistant to meropenem \[[@B5]\]. We previously found that the susceptibility rate of IMP-6-positive *Escherichia coli* was higher for imipenem than for meropenem \[[@B3]\]. Thus, IMP-6-producing isolates may be erroneously categorized as imipenem-susceptible, which could lead to treatment failure in patients.

It is important to distinguish between the genes *bla*~IMP-1~ (encoding IMP-1) and *bla*~IMP-6~ (encoding IMP-6) because of the differences in substrate specificity; these variants can be identified by either DNA sequencing or amplification refractory mutation system (ARMS) PCR \[[@B6]\]. However, these methods are costly and time-consuming, and ARMS PCR requires multiple reaction tubes per sample. Therefore, we developed a simple, rapid multiplex ARMS PCR assay to discriminate between IMP-1 and IMP-6. We designed two sets of Multiplex ARMS PCR primers based on the nucleotide sequences of *bla*~IMP-1~ and *bla*~IMP-6~. Primers IMP-f and IMP-r were designed to recognize the conserved sequences of *bla*~IMP-1~ and *bla*~IMP-6~, while primers IMP-1f and IMP-6r were designed to recognize specific nucleotide sequences of *bla*~IMP-1~ and *bla*~IMP-6~, respectively \[[@B7]\].

PCR amplification using the primer pair IMP-1f (5′-AAGGCAAAACTGGTTGTTCCTA-3′) and IMP-r (5′-CGACTTGTTAGAAATTTAGTTGC-3′) results in a 120-bp *bla*~IMP-1~ gene-specific fragment, and PCR amplification using the primer pair IMP-f (5′-CTCGATCTATCCCCACGTATG-3′) and IMP-6r (5′-TCGTCTCCAACTTCACTGTGA[G]{.ul}C-3′) generates a 350-bp *bla*~IMP-6~ gene-specific fragment (underlined sequences indicate nucleotide alternations for allele-specific primers). The 3′ termini of the primers correspond to the specific nucleotide sequence at position 640 of IMP-1 (AGT, Ser) and IMP-6 (GGT, Gly), respectively. We performed multiplex ARMS PCR amplification using the Qiagen Multiplex PCR Master Mix (Qiagen, Venlo, The Netherlands) with the following conditions: denaturation for 15 minutes at 95℃ and 32 cycles of 10 seconds at 95℃, 30 seconds at 50℃, and 20 seconds at 72℃. DNA fragments were analyzed by electrophoresis. We used IMP-1-producing *E. coli* (NR2406) and IMP-6-producing *E. coli* (NR2407) from Japanese clinical isolates as positive controls. The bands, 120- or 350-bp in size, were obtained within 90 minutes or less ([Fig. 1](#F1){ref-type="fig"}).

We performed this method on 350 carbapenemase-producing clinical isolates collected from general hospitals across Japan from 2012 to 2016 and archived in our laboratory \[[@B4][@B8]\]. We also determined the antibiotic susceptibility of the isolates by the agar dilution method in accordance with CLSI recommendations \[[@B9]\]. The multiplex ARMS PCR results and imipenem and meropenem minimum inhibitory concentration (MIC) ranges of the isolates are shown in [Table 1](#T1){ref-type="table"}. The IMP-1 and IMP-6 producers yielded PCR products of the expected size. We confirmed the accuracy of this method by DNA sequencing of the PCR products (120-bp and 350-bp bands) of three representative strains. Cross-reactivity for other types of carbapenemase producers was not detected, and false-positive or false-negative results were not observed ([Table 1](#T1){ref-type="table"}).

This multiplex ARMS PCR assay successfully discriminated between *bla*~IMP-1~ and *bla*~IMP-6~. Thus, this method could serve as a specific, rapid, and simple alternative for the detection of IMP-1 or IMP-6 producers and could facilitate clinical treatment, infection control, and large-scale IMP producer screening.
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![Representative multiplex ARMS PCR patterns of IMP-1- and IMP-6-producing strains.\
Abbreviations: ARMS, amplification refractory mutation system; Lane M, 100-bp DNA ladder marker.](alm-38-378-g001){#F1}

###### Characteristics of carbapenemase-producing strains used in this study and the multiplex ARMS PCR results

![](alm-38-378-i001)

  Species                   Strains (N)   β-lactamase   MIC range (μg/mL)   Specific band^\*^ (N)   
  ------------------------- ------------- ------------- ------------------- ----------------------- --------------
  *Klebsiella pneumoniae*   31            IMP-1         0.125--64           0.125--64               120 bp (31)
  *Enterobacter cloacae*    18            IMP-1         0.125--4            ≤ 0.06--4               120 bp (18)
  *Klebsiella oxytoca*      9             IMP-1         0.125--1            0.125--2                120 bp (9)
  *Escherichia coli*        5             IMP-1         0.125--1            0.5--2                  120 bp (5)
  *Citrobacter freundii*    2             IMP-1         0.25--1             0.125--0.5              120 bp (2)
  *Escherichia coli*        170           IMP-6         ≤ 0.06--1           0.125--32               350 bp (170)
  *Klebsiella pneumoniae*   87            IMP-6         ≤ 0.06--0.5         0.25--16                350 bp (87)
  *Enterobacter cloacae*    1             IMP-6         0.125               0.25                    350 bp (1)
  *Klebsiella pneumoniae*   12            KPC           2--32               2--64                   None
  *Escherichia coli*        12            NDM           1--16               0.5--32                 None
  *Klebsiella pneumoniae*   2             OXA-48 like   0.5--1              0.5                     None
  *Citrobacter freundii*    1             VIM           1                   1                       None

^\*^120-bp band, IMP-1-specific band; 350-bp band, IMP-6-specific band.

Abbreviations: MIC, minimum inhibitory concentration; IPM, imipenem; MEPM, meropenem; ARMS, amplification refractory mutation system.
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